Safety and efficacy of chronic weekly rozanolixizumab in generalized myasthenia gravis: the randomized open-label extension MG0004 study
Vera Bril, Artur Drużdż, Julian Großkreutz, Ali A. Habib et autres
ca, de, us, it, fr, jp, dk (code pays fourni par la source)